The University of Kentucky College of Pharmacy will host its tenth annual Therapeutics, Outcomes, Discovery & Delivery (TODD) Symposium from 8:00 a.m. – 5:30 p.m. on Tuesday, Nov. 12, 2019, in room 124 of the Lee T. Todd, Jr. Building.
The TODD Symposium will discuss the development of substance use disorder therapeutics from prevention to cure. The symposium will also highlight the discoveries of therapeutics and diagnostics to address the unmet clinical need for patients suffering from substance use disorder within the Commonwealth and beyond.
The TODD Symposium brings together scientists from around the world and across campus to discuss the latest scientific advances in pharmaceutical sciences.
“It’s a unique opportunity to discuss how we can address significant clinical problems that disproportionately affect Kentucky. The event is a true collaboration across UK’s campus, and I think attendees will find that there’s something for everyone from basic scientists to those interested in public policy,” said Jill Turner, UK College of Pharmacy professor and chair of the 2019 TODD Symposium.
The 2019 TODD Symposium keynote speakers are:
Additional featured speakers include:
A panel discussion titled “Considerations Regarding Further Development of SUDs as a Priority Research Area” will also be featured and include UK experts from across campus. All UK and regional scientific communities are welcome to attend the TODD Symposium. Registration is free and must be completed online by Nov. 4, 2019, in order to receive lunch.
Support for the symposium is provided by the UK Center for Clinical and Translational Science, the UK College of Pharmacy, UK College of Arts & Sciences, and the UK College of Public Health.